Ensysce Biosciences (ENSC) reported Q3 EPS
Tweet
Share
E-mailGet Alerts ENSC Hot Sheet
Join SI Premium – FREE
Ensysce Biosciences (NASDAQ: ENSC) reported Q3 EPS of ($1.29).
For earnings history and earnings-related data on Ensysce Biosciences (ENSC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aristocrat Leisure (ALL:AU) (ARLUF) PT Raised to AUD66 at RBC Capital
- RBC Capital Starts Applied Aerospace & Defense Inc (AADX) at Outperform
- Goldman Sachs Reiterates Buy Rating on NetEase.com (NTES)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
